Ahmed F Abdel-Magid

39PUBLICATIONS
0CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiologically active moleculesClinical pharmacology and therapeuticsMolecular targetsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jul 14, 2026
The Great Potential of the Cluster of Differentiation 38 (CD38) Inhibitors in the Treatment of Cancer and Age-Related Metabolic dysfunction.

|Jul 14, 2026
NADPH-Oxidase 4 (NOX4) Inhibitors as a Treatment for Idiopathic Pulmonary Disease, Fibrotic Diseases, Inflammatory Diseases, and Cancer.

|Jul 14, 2026
Inhibitors of Enhancer of Zeste Homologue 2 (EZH2) as Treatment for Cancer, Autoimmune, and Other Diseases.

|Jul 14, 2026
The Hyperpolarization-Activated, Cyclic-Nucleotide (HCN) Ion Channel Inhibitors as Potential Therapy for Pain, CNS Disorders, Psychiatric Disorders, and Tinnitus.

|May 20, 2026
Inhibitors of the Neutral Amino Acid Transporter SLC6A19 May Treat Diseases or Disorders Associated with Abnormal Amino Acid Metabolism, Epithelial Amino Acid Transport, and/or Amino Acid Levels.

|May 20, 2026
Phosphodiesterase 9 (PDE9) Inhibitors May Provide Effective Treatments for Neurodegenerative, Cardiovascular and Other Diseases.

Pageof 7

Frequent Collaborators